Alendronate tablets 35mg “YD,” produced by Yoshindo, features Alendronate sodium hydrate, a bisphosphonate indicated for the prevention and treatment of osteoporosis and Paget’s disease of bone. The standard is 35mg per tablet, identified by YJ code 3999018F2133.
Alendronate tablets 35mg “YD”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
